483 Alidac Pharmaceuticals Mar 2019

483 Alidac Pharmaceuticals Mar 2019

Matthew Casale FDA$119.00 - Available Now

FDA investigators audited the Alidac Pharmaceuticals - Dist. Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 26 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Mar 2019
  • Location: Dist. Ahmedabad, India
  • FEI: 3007621329
Add To Cart